Here’s why activist billionaire investor Carl Icahn is telling Cigna shareholders to vote against its purchase of Express Scripts. Also, what Regeneron Pharmaceuticals and bluebird bio's new deal means for investors.
Sorry we couldn't complete your registration. Please try again.
You must accept the Terms and conditions to register